A New Coronavirus Estimation Global Score for Predicting Mortality During Hospitalization in Patients with COVID-19

Hesong Zeng1, Xingwei He1, Wanjun Liu1

  • 1Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei 430030, China.

Cardiology Discovery
|December 21, 2022
PubMed

Insights

A new Coronavirus Estimation Global (CORE-G) score was developed to predict in-hospital death in COVID-19 patients. This validated tool aids in early risk stratification for better patient outcomes during hospitalization.

Area of Science:

  • Medical Informatics
  • Epidemiology
  • Clinical Medicine

Background:

  • The COVID-19 pandemic necessitates effective tools for predicting patient mortality.
  • Risk stratification models are crucial for identifying high-risk COVID-19 patients requiring intensive care.
  • Existing models may not fully capture the complexity of in-hospital death predictors.

Purpose of the Study:

  • To develop and validate a novel risk score system for predicting in-hospital death in COVID-19 patients.
  • To establish an early identification method for COVID-19 patients at high risk of mortality.
  • To create a practical tool for clinical use in managing COVID-19 patients.

Main Methods:

  • A retrospective analysis of 821 COVID-19 patients from three centers.
  • Patients were divided into developmental (n=411) and validation (n=410) cohorts.
  • The Coronavirus Estimation Global (CORE-G) score was constructed using demographic, symptomatic, and laboratory variables.

Main Results:

  • The CORE-G score incorporates 18 variables (5 demographic, 2 symptomatic, 11 laboratory).
  • The model demonstrated good fit in both developmental (H=3.210, P=0.880) and validation (H=6.948, P=0.542) groups.
  • High predictive performance was observed with AUCs of 0.955 (developmental) and 0.937 (validation), showing excellent sensitivity and specificity.

Conclusions:

  • The CORE-G score effectively estimates the risk of in-hospital death for COVID-19 patients.
  • This score represents a significant advancement towards clinical application for outcome prediction.
  • The CORE-G score facilitates early identification and management of critically ill COVID-19 patients.
Abstract

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
222
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
110
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
173